Abstract
BackgroundAlthough the long-term efficacy, tolerability, and safety of methotrexate (MTX) in patients with rheumatoid arthritis (RA) are well documented, the clinical response and incidence of adverse events (AE) vary. Data...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have